IRIS
CARLO STELLA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.549
EU - Europa 1.262
AS - Asia 1.102
AF - Africa 216
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 9.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.484
CN - Cina 511
SG - Singapore 511
FI - Finlandia 362
IE - Irlanda 248
NG - Nigeria 205
DE - Germania 173
FR - Francia 121
IT - Italia 73
NL - Olanda 71
CA - Canada 64
GB - Regno Unito 58
CZ - Repubblica Ceca 29
SE - Svezia 29
RU - Federazione Russa 25
BE - Belgio 21
IL - Israele 21
BR - Brasile 18
TR - Turchia 16
CL - Cile 11
IN - India 11
LT - Lituania 10
AT - Austria 9
EG - Egitto 8
IR - Iran 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AR - Argentina 6
ES - Italia 6
JP - Giappone 6
RO - Romania 6
HK - Hong Kong 5
AU - Australia 3
BD - Bangladesh 3
CH - Svizzera 3
GR - Grecia 3
PE - Perù 3
PL - Polonia 3
UA - Ucraina 3
AM - Armenia 2
CO - Colombia 2
IQ - Iraq 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DK - Danimarca 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
KR - Corea 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 9.181
Salva come PNG Salva come JPEG
Città #
Wilmington 1.309
Chandler 1.266
San Mateo 502
Shanghai 451
Helsinki 359
Singapore 342
Ann Arbor 332
Dublin 247
Leawood 243
Boardman 232
Lawrence 225
Princeton 225
Benin City 205
Fairfield 124
Paris 112
New York 111
Ashburn 96
Woodbridge 95
Amsterdam 69
Toronto 56
London 51
Seattle 42
San Diego 31
Norwalk 27
Falls Church 26
Brno 23
Brussels 21
Milan 21
Los Angeles 18
Santa Clara 17
Kocaeli 15
Phoenix 15
Monmouth Junction 13
Gunzenhausen 12
Redmond 10
Abbiategrasso 9
Moscow 9
Munich 9
Nuremberg 8
Pune 8
Vienna 8
Andover 6
Houston 6
Redwood City 6
Berlin 5
Clearwater 5
Des Moines 5
Falkenstein 5
Munro 5
Novokuznetsk 5
Olomouc 5
Cambridge 4
Frankfurt am Main 4
Hangzhou 4
Hanover 4
Sacramento 4
Saint Paul 4
Al Mansurah 3
Beijing 3
Cardiff 3
Cologne 3
Cupertino 3
Freiburg im Breisgau 3
Hong Kong 3
Las Vegas 3
Lima 3
Lissone 3
Montréal 3
Naples 3
Pozzuoli 3
Raleigh 3
Shenyang 3
Athens 2
Azzano Decimo 2
Canegrate 2
Curitiba 2
Eden Prairie 2
Genoa 2
Guangzhou 2
Henderson 2
Jacksonville 2
Kunming 2
La Canada Flintridge 2
Lappeenranta 2
Leipzig 2
Newark 2
Ottawa 2
Riga 2
Rome 2
St Petersburg 2
Stuttgart 2
São Paulo 2
Tappahannock 2
Tel Aviv 2
Voronezh 2
Yerevan 2
Adliswil 1
Anita Garibaldi 1
Apo 1
Auckland 1
Totale 7.168
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 137
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 73
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 69
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 66
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 65
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 62
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 61
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 60
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 60
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 60
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 59
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 59
Radioimmunotherapy and secondary leukemia : a case report 58
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 58
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 58
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 57
Cell therapy: achievements and perspectives 57
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 57
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 57
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 56
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 56
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 55
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 54
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 53
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 53
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 52
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 52
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 52
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 52
Amifostine (WR-2721) selective protection against melphalan genotoxicity 52
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 52
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 52
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 52
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 51
Stem cells and stem cell transplantation 51
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 51
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma 50
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 49
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment 49
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 49
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 49
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 49
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 49
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 49
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 48
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma 48
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 48
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME 47
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 46
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study 46
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma 46
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 46
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 46
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 45
Ex vivo expansion of hematopoietic cells and their clinical use 45
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation sf the c-jun amino-terminal kinases in stromal cells 45
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 45
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 45
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 45
IN VITRO GROWTH OF BONE MARROW-DERIVED MULTIPOTENT AND LINEAGE-RESTRICTED HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES 45
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 44
OLIGODEOXYNUCLEOTIDES ANTISENSE TO C-ABL SPECIFICALLY INHIBIT ENTRY INTO S-PHASE OF CD34(+) HEMATOPOIETIC-CELLS AND THEIR DIFFERENTIATION TO GRANULOCYTE-MACROPHAGE PROGENITORS 44
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 44
High-dose sequential chemotherapy and in vivo Rituximab-purged stem cell autografting in mantle cell lymphoma : a 10-year update of the R-HDS regimen 44
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 44
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 44
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 44
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 44
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 44
NATURAL-KILLER-CELL REGENERATION AFTER TRANSPLANTATION WITH MAFOSFAMIDE PURGED AUTOLOGOUS BONE-MARROW 44
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 44
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation : results from a named patient program at four Italian centers 44
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 44
Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Agonistic Receptors for Cancer Therapy 43
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 43
Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood 43
Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation 43
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 42
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 42
USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH LYMPHOID MALIGNANCIES TRANSPLANTED WITH UNPURGED OR ADJUSTED-DOSE MAFOSFAMIDE-PURGED AUTOLOGOUS MARROW 42
INTERFERONS AS BIOLOGIC MODULATORS OF HEMATOPOIETIC-CELL PROLIFERATION AND DIFFERENTIATION 42
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 42
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide 42
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial 42
EFFECTS OF RECOMBINANT HUMAN H-SUBUNIT AND L-SUBUNIT FERRITINS ON INVITRO GROWTH OF HUMAN GRANULOCYTE MONOCYTE PROGENITORS 42
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide 42
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses 41
EFFECTS OF RECOMBINANT ALPHA-INTERFERONS AND GAMMA-INTERFERONS ON THE INVITRO GROWTH OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS (CFU-GEMM, CFU-MK, BFU-E, AND CFU-GM) FROM PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA 41
Effects of the tyrosine kinase inhibitor AG957 and an anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells 41
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor 41
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 41
High response rate and manageable toxicity with an intensive, short-term chemotherapy program for Burkitt’s lymphoma in adults 41
DEFECTIVE INVITRO GROWTH OF THE HEMATOPOIETIC PROGENITOR CELLS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME 41
Nonmyeloablative conditioning, unmanipulated haploidentical stem cell transplantation and post-infusion cyclophosphamide for advanced lymphomas 41
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection 41
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 41
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up 41
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF 41
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 41
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma 41
Totale 4.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.265 4 17 6 7 9 751 336 147 445 303 8 232
2021/20221.277 68 5 19 275 19 20 30 165 130 193 286 67
2022/20233.390 487 102 293 411 326 292 0 310 604 281 236 48
2023/20241.820 139 218 335 41 30 128 67 132 24 36 280 390
2024/2025647 88 65 33 69 85 307 0 0 0 0 0 0
Totale 9.399